NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

$2.22  -0.17 (-7.11%)
As of 01/24/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/01/2014
Outstanding shares:  5,340,193
Average volume:  246,729
Market cap:   $11,801,827
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.60
PB ratio:   11.87
PS ratio:   3.92
Return on equity:   6,909.87%
Net income %:   -1,690.90%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy